Siddharth Lath

Seasoned Consultant Medical Oncologist with a robust background at HCG Aastha Cancer Centre, adept in managing a wide spectrum of oncological subspecialties. Proven expertise in chemotherapy, targeted therapy, and leadership in critical care settings. Demonstrates exceptional skill in bone marrow transplants and patient management, ensuring high-quality care and treatment outcomes.

• Date of Birth: 10/06/81
• Gender: Male
• Nationality: Indian

• English
• Hindi
• Marwari (Rajasthani)

1. As Speaker on the role of targeted therapy in Alk positive NSCLC in National Cardio-Oncology Conference in Ahmedabad in October 2024

2. As Panelist in best of SABCS 2025 in Ahmedabad on Her2 positive and Her2 low breast cancer

3. As Panelist in Advances on lung cancer conference organised by HCG Cancer Centre Ahmedabad in January 2025.

Attended various national conferences  :

A. Indian Cancer Congress 2023 - Mumbai

B. ISMPO 2018, Indore

C. Apollo Cancer Conclave, Hyderabad, 2018

D. Immuno-Oncology Society of India Conference, Jaipur

E. Advances in Oncology, Faridabad, 2021

F. CAR-T Cell Update, New Delhi , 2023

• Co-investigator for the trial on efficacy of biosimilar Nivolumab in lung cancer patients, developed by Zydus Lifeciences.
• Correlation of PD-L1 expression level with response to anti-PD1 and anti-PD-L1 immunotherapy agents in different tumor types.
• Received special award and recognition of Commendable efforts by National Board of Examinations in Medical Sciences, New Delhi for the study on PDL1 level and immunotherapy.
• A comparative study of accuracy of estimate of Glomerular filtration rate using Cockcroft-Gault equation, abbreviated Modification of Diet in Renal Disease equation and Mayo Clinic Quadratic equation